Should I buy Allstate (ALL) stock or is it too late?
⭐ The most reliable of them, either direction: HSBC — 76% of its targets hit on this sector (25 calls tested). It aims for $264 (+2.5 %), call made on July 7, 2026, maturing on July 7, 2027 (52 d ago).
Firm-by-firm track record on Allstate
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Piper Sandler | 89 % | +23.1 % | 19 | $300 +16% |
| UBS | 90 % | +19.5 % | 10 | $275 +7% |
| Keefe, Bruyette & Woods | 96 % | +17.4 % | 23 | $250 -3% |
| Morgan Stanley | 100 % | +15.0 % | 8 | $240 -7% |
| Raymond James | 72 % | +14.3 % | 25 | $300 +16% |
| BMO Capital | 100 % | +11.4 % | 5 | $244 -5% |
| Citigroup | 67 % | +10.1 % | 27 | $240 -7% |
| JP Morgan | 69 % | +9.4 % | 16 | $292 +13% |
✅ Reasons to believe
- The most reliable firm on ALL, Evercore ISI Group (100% hit rate, 2 scored calls), targets $262 (call made on August 6, 2026, maturing on August 6, 2027) (+2%) in its most recent call, and $240 (call made on July 10, 2026, maturing on July 10, 2027) (-7%) in the one coming due soonest.
- Pays a dividend (1.7% yield), raised for 15 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~5) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 14 ratings, 5 are neutral and 4 are sells.
- Limited upside: the median target is only +2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on ALL
Median target $263 (+2%) · 14 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Allstate now?
We won't decide for you. The facts: 36% of analysts rate it a buy, median target $263 (+2%), and Evercore ISI Group (most reliable on ALL, 100%) targets $262. Weigh that against valuation (P/E ~5). This is not personalized advice.
Is it too late to invest in Allstate?
The stated upside is small: the median target ($263) sits just +2% from the price ($258) (most reliable on ALL: Evercore ISI Group, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Allstate still worth investing in?
It depends on the gap between the price ($258) and its estimated value: analysts target $263 on median (+2%), with 36% buys (most reliable on ALL: Evercore ISI Group, 100%). Cross-check with their real reliability on ALL and the cautions above. Information, not advice.
What's the main risk in buying ALL?
The consensus is not unanimous: of 14 ratings, 5 are neutral and 4 are sells.
→ Go deeper: the full Allstate profile (consensus, analyst reliability, price target, performance).